Not a single person is alive today that took a mRNA shot pre 2018. Not one single one | |
TaoAmor User ID: 80766838 ![]() 08/26/2021 12:16 AM Report Abusive Post Report Copyright Violation | Not only did google purge so did researchgate bioarxiv nature and hundreds of others. Quoting: roguetechie81 If the evidence is still online anywhere it's unlisted to avoid being found by a search engine meaning if you don't know the direct link you won't ever get it. Fuck Google. If it's not part of the narrative or an item/service for sale, they don't provide shit in a search. More crimes against humanity. . i'd heard m rn a was in "B-ILL" G ates' zika vax, Brasil |
Raise Christians User ID: 80510765 ![]() 08/26/2021 12:52 AM Report Abusive Post Report Copyright Violation | |
Anonymous Coward User ID: 50188346 ![]() 08/26/2021 12:54 AM Report Abusive Post Report Copyright Violation | Trial on ferrets yielded severe hepatitis in mRNA injected specimens. "Extra caution should be taken in proposed human trials of SARS vaccines due to the potential liver damage from immunization and virus infection" [link to www.cidrap.umn.edu (secure)] Trial on mice yielded Th2 hypersensitivity, resulting in destruction of lung tissue. "challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated." [link to journals.plos.org (secure)] "Type II hypersensitivity is an antibody-dependent process in which specific antibodies bind to antigens, resulting in tissue damage or destruction” [link to www.sciencedirect.com (secure)] "There are no specific guidelines for use of messenger RNA (mRNA) vaccines or contraindications to mRNA vaccines. No large trials of any mRNA vaccine have been completed yet. The only evidence on safety of mRNA vaccines comes from small phase I and phase II trials of SARS-CoV-2 vaccines, with follow-up typically less than two months. Systemic adverse events such as fatigue, muscle aches, headache, and chills are common. Severe systemic adverse events were reported by 5 to 10 percent of trial subjects. Localized adverse events such as pain at the injection side are common. Both systemic and local adverse events usually are resolved within one or two days. The rate and severity of adverse events appears to be higher for the second dose of vaccine than for the first. Higher vaccine doses appear to increase the rate and severity of adverse events. Larger trials of SARS-CoV-2 vaccines are in progress, with results expected in mid-2021. There is not sufficient evidence to support any conclusions on the comparative safety of different mRNA vaccines. Direct evidence on the comparative safety of mRNA vaccines and other vaccines is lacking." [link to www.uphs.upenn.edu] |
stillintrigued User ID: 41925838 ![]() 08/26/2021 01:29 AM Report Abusive Post Report Copyright Violation | The question is who was taking mRNA shots back in 2018. Quoting: Plants Constant they did not even have an mRNA shot then supposedly. well probably in the lab it was developed in as we know. so if you have links to data that show mRNA deaths prior to it being rolled out in late 2020, please provide. otherwise ...pfft First, I have to state this, we are not dealing with a virus called 'Covid', the virus that is killing people is SARS, in which ALL OF THE ANIMALS DIED and ALL of the researchers experimenting with 'vaccines for SARS' recommended that NO vaccine ever be given to humans for SARS as they all failed miserably. The Story of MRNA ( according to the internet) Less than 50% [link to www.statnews.com (secure)] Before messenger RNA was a multibillion-dollar idea, it was a scientific backwater. And for the Hungarian-born scientist behind a key mRNA discovery, it was a career dead-end. Katalin Karikó spent the 1990s collecting rejections. Her work, attempting to harness the power of mRNA to fight disease, was too far-fetched for government grants, corporate funding, and even support from her own colleagues. It all made sense on paper. In the natural world, the body relies on millions of tiny proteins to keep itself alive and healthy, and it uses mRNA to tell cells which proteins to make. If you could design your own mRNA, you could, in theory, hijack that process and create any protein you might desire — antibodies to vaccinate against infection, enzymes to reverse a rare disease, or growth agents to mend damaged heart tissue. In 1990, researchers at the University of Wisconsin managed to make it work in mice. Karikó wanted to go further. The problem, she knew, was that synthetic RNA was notoriously vulnerable to the body’s natural defenses, meaning it would likely be destroyed before reaching its target cells. And, worse, the resulting biological havoc might stir up an immune response that could make the therapy a health risk for some patients. |